# The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure

> **NCT06779942** · — · COMPLETED · sponsor: **Bayer** · enrollment: 414 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)
- Acute Respiratory Failure (ARF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06779942
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06779942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06779942, "The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06779942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*